![]() |
|
|
Vol. 28, Issue 11, 1291-1296, November 2000
8-tetrahydrocannabinol to
7-Oxo-
8-tetrahydrocannabinol in Human Liver Microsomes
Department of Hygienic Chemistry, Faculty of Pharmaceutical
Sciences, Hokuriku University (T.M., N.K., S.H., K.W., I.Y.), Hokuriku,
Japan; and Department of Legal Medicine, Kanazawa University Faculty of
Medicine, School of Medicine, Kanazawa, Japan (T.O.)
The human liver enzyme microsomal alcohol oxygenase was able
to oxidize both 7
- and
7
-hydroxy-
8-tetrahydrocannabinol (7
- and
7
-hydroxy-
8-THC) to 7-oxo-
8-THC. The
oxidative activity was determined by using a panel of 12 individual
cDNA-expressed human cytochrome P450s (CYPs) (1A1, 1A2, 2A6, 2B6, 2C8,
2C9-Arg, 2C9-Cys, 2C19, 2D6-Met, 2D6-Val, 2E1 and 3A4). Among the CYP
isoforms examined, CYP3A4 showed the highest activity for both of
substrates. The metabolism of 7
- and
7
-hydroxy-
8-THC to 7-oxo-
8-THC was
also detected for CYPs 1A1 (4.8% of CYP3A4), 1A2 (4.7%), 2A6 (2.3%),
2C8 (16.6%), and 2C9-Cys (5.4%), and CYPs 1A1 (0.4%), 2C8 (1.3%),
2C9-Arg (4.3%), and 2C9-Cys (0.9%), respectively. The 7
- and
7
-hydroxy-
8-THC microsomal alcohol oxygenase
activities in human liver were significantly inhibited by addition of
100 µM troleandomycin, 1 µM ketoconazole, and anti-CYP3A antibody,
although these activities were not inhibited by 1 µM 7,8-benzoflavone
and 50 µM sulfaphenazole. When the substrates were incubated with the
CYP3A4-expressed microsomes under oxygen-18 gas phase, atmospheric
oxygen was incorporated into 35% of 7-oxo-
8-THC formed
from 7
-OH-
8-THC, but only 12% of
7-oxo-
8-THC formed from 7
-OH-
8-THC.
These results indicate that CYP3A4 is a major isoform responsible for
the oxidation of 7
- and 7
-hydroxy-
8-THC to
7-oxo-
8-THC in liver microsomes of humans, although the
oxidation mechanisms for 7
- and 7
-hydroxy-
8-THC
might be different.
This article has been cited by other articles:
![]() |
C. Rodriguez-Antona, M. Axelson, C. Otter, A. Rane, and M. Ingelman-Sundberg A Novel Polymorphic Cytochrome P450 Formed by Splicing of CYP3A7 and the Pseudogene CYP3AP1 J. Biol. Chem., August 5, 2005; 280(31): 28324 - 28331. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Wynn, K. L. Cozza, M. J. Zapor, G. W. Wortmann, and S. C. Armstrong Antiretrovirals, Part III: Antiretrovirals and Drugs of Abuse Psychosomatics, February 1, 2005; 46(1): 79 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsunaga, H. Tanaka, S. Higuchi, K. Shibayama, N. Kishi, K. Watanabe, and I. Yamamoto Oxidation Mechanism of 7-Hydroxy-Delta 8-tetrahydrocannabinol and 8-Hydroxy-Delta 9-tetrahydrocannabinol to the Corresponding Ketones by CYP3A11 Drug Metab. Dispos., November 1, 2001; 29(11): 1485 - 1491. [Abstract] [Full Text] [PDF] |
||||